Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 18, 2016

Primary Completion Date

August 14, 2017

Study Completion Date

December 6, 2017

Conditions
Plaque Psoriasis
Interventions
DRUG

Etanercept

Administered subcutaneously twice weekly for 12 weeks then once weekly for an additional 12 weeks.

Trial Locations (22)

10075

Research Site, New York

20850

Research Site, Rockville

27834

Research Site, Greenville

31217

Research Site, Macon

32204

Research Site, Jacksonville

33134

Research Site, Coral Gables

40217

Research Site, Louisville

48059

Research Site, Fort Gratiot

48103

Research Site, Ann Arbor

48346

Research Site, Clarkston

63117

Research Site, St Louis

77082

Research Site, Houston

78218

Research Site, San Antonio

85254

Research Site, Scottsdale

89052

Research Site, Henderson

90211

Research Site, Beverly Hills

90404

Research Site, Santa Monica

92663

Research Site, Newport Beach

92708

Research Site, Fountain Valley

94583

Research Site, San Ramon

08520

Research Site, East Windsor

07044

Research Site, Verona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY